Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Concurrent and Adjuvant Cisplatin and Docetaxel in LACC
NCT02703961Phase 3Unknown
- Sponsor
- Air Force Medical University
- Start
- Feb 2016
- Primary completion
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of docetaxel in Cervical Cancer (CC) (2 arms), sponsored by Air Force Medical University. Primary endpoint: Disease Free Survival at 3 years. Status: unknown.
02
Drugs
docetaxel
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT02703961.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02703961.